Marinus Verwijs, CHIEF TECHNICAL OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 9,096 shares at $28.87 ($264K) on 2024-04-01, disclosed to the SEC on 2024-04-03.
Scheduled sale ($264k) by CHIEF TECHNICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.87 | 3,796 | $110K | 41.5% |
| 2 | $28.87 | 3,796 | $110K | 41.5% |
| 3 | $30.00 | 1,504 | $45K | 17.1% |
| Total | $29.06 avg | 9,096 | $264K | 100% |
| Filing → |
| AVTE | SELL | 2024-03-20 | $277K | — | Filing → |
| AVTE | SELL | 2023-11-03 | $10K | — | Filing → |
| AVTE | SELL | 2023-05-05 | $16K | — | Filing → |